Zobrazeno 1 - 10
of 123
pro vyhledávání: '"Flavia Foca"'
Autor:
Laura Ridolfi, Lorena Gurrieri, Nada Riva, Jenny Bulgarelli, Francesco De Rosa, Massimo Guidoboni, Valentina Fausti, Nicoletta Ranallo, Sebastiano Calpona, Marcella Tazzari, Massimiliano Petrini, Anna Maria Granato, Elena Pancisi, Flavia Foca, Monia Dall’Agata, Isabella Bondi, Elena Amadori, Pietro Cortesi, Chiara Zani, Valentina Ancarani, Alessandro Gamboni, Antonio Polselli, Giuseppe Pasini, Daniela Bartolini, Giuseppe Maimone, Donatella Arpa, Luigino Tosatto
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundGlioblastoma (GBM) is a poor prognosis grade 4 glioma. After surgical resection, the standard therapy consists of concurrent radiotherapy (RT) and temozolomide (TMZ) followed by TMZ alone. Our previous data on melanoma patients showed that
Externí odkaz:
https://doaj.org/article/0f22af35c6464221aedfb048e9a1cf74
Autor:
Alessandro Cafaro, Flavia Foca, Oriana Nanni, Marco Chiumente, Marina Coppola, Paolo Baldo, Sabrina Orzetti, Fiorenza Enrico, Vito Ladisa, Rosa Lerose, Patrizia Nardulli, Piera Maiolino, Federica Gradellini, Anna Rita Gasbarro, Gisella Carrucciu, Riccardo Provasi, Paola Cristina Cappelletto, Alessandra Pasqualini, Stefano Vecchia, Marianna Veraldi, Adele Emanuela De Francesco, Lucio Crinò, Angelo Delmonte, Carla Masini
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionThe phase III Keynote-189 trial established a first-line treatment combining pembrolizumab with pemetrexed and platinum as a standard treatment for patients with stage IV non-small cell lung cancer (NSCLC) without known EGFR and ALK drive
Externí odkaz:
https://doaj.org/article/ac61704f545c4c6cbdb99105082d3c5c
Autor:
Giorgia Micucci, Agnese Mattei, Monica Poggiaspalla, Gerardo Musuraca, Federica Frabetti, Flavia Foca, Giulio Giordano, Mariasanta Napolitano, Alessandro Lucchesi
Publikováno v:
HemaSphere, Vol 7, p e437643d (2023)
Externí odkaz:
https://doaj.org/article/078bae0c7f314046b2cbd0ce58269dc8
Autor:
Martine Bocchini, Marcella Tazzari, Sara Ravaioli, Filippo Piccinini, Flavia Foca, Michela Tebaldi, Fabio Nicolini, Ilaria Grassi, Stefano Severi, Raffaele Adolfo Calogero, Maddalena Arigoni, Joerg Schrader, Massimiliano Mazza, Giovanni Paganelli
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs) are rare diseases encompassing pancreatic (PanNETs) and ileal NETs (SINETs), characterized by heterogeneous somatostatin receptors (SSTRs) expression. Treatments for inoperable GEP-NETs are li
Externí odkaz:
https://doaj.org/article/e7851a614d4d443b97fb8a0ee8e2f70d
Autor:
Chiara Liverani, Chiara Spadazzi, Toni Ibrahim, Federica Pieri, Flavia Foca, Chiara Calabrese, Alessandro De Vita, Giacomo Miserocchi, Claudia Cocchi, Silvia Vanni, Giorgio Ercolani, Davide Cavaliere, Nicoletta Ranallo, Elisa Chiadini, Giovanna Prisinzano, Stefano Severi, Maddalena Sansovini, Giovanni Martinelli, Alberto Bongiovanni, Laura Mercatali
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2023)
IntroductionNeuroendocrine neoplasms (NENs) are a rare group of tumors exceptionally heterogeneous, with clinical presentation ranging from well differentiated more indolent tumors to poorly differentiated very aggressive forms. Both are often diagno
Externí odkaz:
https://doaj.org/article/6702750d458546d594d1121a5c66b84f
Autor:
Manlio Monti, Andrea Prochowski Iamurri, David Bianchini, Chiara Gallio, Luca Esposito, Daniela Montanari, Silvia Ruscelli, Chiara Molinari, Flavia Foca, Alessandro Passardi, Giovanni Vittimberga, Paolo Morgagni, Giovanni Luca Frassineti
Publikováno v:
Nutrients, Vol 15, Iss 16, p 3604 (2023)
Background and aims: Perioperative treatment is currently the gold standard approach in Europe for locally advanced gastric cancer (GC). Unfortunately, the phenomenon of patients dropping out of treatment has been frequently observed. The primary aim
Externí odkaz:
https://doaj.org/article/238e8a0066f048579c7fe243a6573d6a
Autor:
Alberto Bongiovanni, Flavia Foca, Manuela Fantini, Maria Rosachiara Forcignanò, Fabrizio Artioli, Rossana Berardi, Enrico Campadelli, Giuseppe Procopio, Francesco Silvestris, Nada Riva, Lorena Gurrieri, Silvia Angela Debonis, Giandomenico Di Menna, Valentina Fausti, Federica Recine, Roberto Vespignani, Toni Ibrahim
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Bone metastases (BM) are still the main cause of morbidity in cancer patients because of skeletal-related events (SREs) that reduce quality of life. They have also led to increased social and healthcare costs. At present, data available on B
Externí odkaz:
https://doaj.org/article/693a0fc1e87149f99ffcaa4f3dfc147a
Evaluating the appropriateness of chemotherapy in a low‐resource cancer centre in sub‐Saharan Africa
Autor:
Patrizia Serra, Deogratias M. Katabalo, Nestory Masalu, Dino Amadori, Salustia Bugingo, Flavia Foca, Sara Bravaccini, Caterina Donati, Lauro Bucchi, Carla Masini
Publikováno v:
Cancer Medicine, Vol 9, Iss 1, Pp 133-140 (2020)
Abstract Background To evaluate the appropriateness of chemotherapy use at the Oncology Department of the Bugando Medical Centre of Mwanza, Tanzania. Methods The study was an observational prevalence‐based study designed to evaluate a single‐chem
Externí odkaz:
https://doaj.org/article/b7a637a2c59f4ef6aa4d418e50d858e8
Autor:
Alessandro Passardi, Flavia Foca, Orazio Caffo, Carlo Alberto Tondini, Alberto Zambelli, Roberto Vespignani, Giulia Bartolini, Francesco Giulio Sullo, Daniele Andreis, Marco Dianti, Claudio Eccher, Enrico Maria Piras, Stefano Forti
Publikováno v:
Journal of Medical Internet Research, Vol 24, Iss 1, p e27349 (2022)
BackgroundA platform designed to support the home management of oral anticancer treatments and provide a secure web-based patient–health care professional communication modality, ONCO-TreC, was tested in 3 cancer centers in Italy. ObjectiveThe ove
Externí odkaz:
https://doaj.org/article/6737cb9bfd2f4b27aa25f8407dd369cb
Autor:
Alberto Bongiovanni, Flavia Foca, Jessica Menis, Stefania Luigia Stucci, Fabrizio Artioli, Valentina Guadalupi, Maria Rosachiara Forcignanò, Manuela Fantini, Federica Recine, Laura Mercatali, Chiara Spadazzi, Marco Angelo Burgio, Valentina Fausti, Anna Miserocchi, Toni Ibrahim
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
IntroductionBone metastases (BMs) are a negative prognostic factor in patients with non-small cell lung cancer (NSCLC). Although immune-checkpoint inhibitors (ICIs) have dramatically changed the therapeutic landscape of NSCLC, little information is a
Externí odkaz:
https://doaj.org/article/efaf44bda0a24525b2e67623d8a9d899